Table 1.
General characteristics of the study subjects.
| Variable | Postbiotic group (n = 56) |
Placebo group (n = 55) |
P value |
|---|---|---|---|
| Age (years)a | 60.64 ± 11.85 | 59.64 ± 8.39 | 0.820 d |
| Weight (kg)a | 78.25 ± 10.98 | 78.64 ± 7.27 | 0.127 d |
| Male sex, n (%) | 50 (90) | 40 (80) | 0.176 c |
| Comorbid conditions, n (%) | |||
| Type 2 diabetes n (%) | 12 (21.5) | 12 (21.8) | 1.00 c |
| Cardiovascular diseases n (%) | 17 (30) | 8 (15) | 0.068 c |
| Glasgow Coma Scale (GCS) | 5.89 ± 1.61 | 6.07 ± 1.84 | 0.570 d |
| APACHE II score a | 11.88 ± 3.22 | 12.25 ± 3.69 | 0.574 d |
| FBS a | 126.21 ± 7.07 | 107.78 ± 21.4 | 0.906 d |
| SBP a | 128.86 ± 20.11 | 122.91 ± 15.17 | 0.097 d |
| DBP a | 82.64 ± 11.9 | 79.33 ± 13.5 | 0.174 d |
| Length of ICU stay, days a | 6.24 ± 1.1 | 6.34 ± 2.1 | 0.906 d |
| Hospital stays, days a | 9.9 ± 1.6 | 10.17 ± 1.8 | 0.527 d |
| Mortality, n (%) | 2 (3.6) | 4 (7.2) | 0.438 c |
| Compliance rate, (%) | 84 | 85 | 0.052 c |
MD: Mean/Median of difference.
a- Values are expressed as the mean (SD).
c- Chi-square test.
d- Independent samples t test.